Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    pemphigus
Show Display Options
Rank Status Study
1 Recruiting Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Interventions: Drug: VAY736;   Drug: Placebo to VAY736
2 Terminated Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
Condition: Pemphigus Vulgaris
Interventions: Drug: intravenous immunoglobulin;   Drug: cyclophosphamide
3 Unknown  Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
Condition: Pemphigus
Intervention: Drug: Rituximab
4 Not yet recruiting Identification of Vulnerability Factors in the Course of Pemphigus Patients
Conditions: Pemphigus;   Dermatological Disease
Intervention: Behavioral: psychological support and therapeutic education program
5 Active, not recruiting Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
Condition: Pemphigus Disease
Intervention: Drug: General Corticotherapy
6 Active, not recruiting Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Condition: Pemphigus
Intervention: Drug: Rituximab and Cyclophosphamide IV
7 Unknown  Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus
Condition: Pemphigus
Intervention: Drug: Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
8 Recruiting Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
Condition: Pemphigus
Intervention: Drug: Sirolimus (formerly known as Rapamycin)
9 Completed
Has Results
Use of Infliximab for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Infliximab;   Drug: Prednisone;   Other: Placebo
10 Completed Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Enbrel (Etanercept)
11 Completed Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Condition: Pemphigus Vulgaris
Interventions: Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
12 Recruiting Wound Dressings for Pemphigus and Pemphigoid
Conditions: Pemphigus;   Pemphigoid
Interventions: Device: Cotton gauze with petrolatum;   Device: Cellulose acetate with petrolatum;   Device: Nanocrystalline silver (Acticoat);   Device: Carboxymethylcellulose with ionic silver (Aquacel Ag)
13 Completed Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Condition: Pemphigus
Intervention: Drug: Rituximab
14 Completed European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
Condition: Pemphigus
Intervention: Drug: dexamethasone (50mg 1dd6, 3 consecutive days/month)
15 Recruiting Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Biological: Ofatumumab;   Biological: Placebo
16 Completed Use of KC706 for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: KC706
17 Completed Effect of Anti CD20 in Pemphigus Desease
Condition: Pemphigus
Intervention: Drug: Mabthera
18 Completed Safety Study of PI-0824 to Treat Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PI-0824
19 Terminated Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Dapsone
20 Completed
Has Results
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
Condition: Pemphigus Vulgaris (PV)
Interventions: Drug: Mycophenolate Mofetil 2 g/Day;   Drug: Mycophenolate Mofetil (MMF) 3 g/Day;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years